Artificial antibodies were developed that fight against the tumor, using different routes, such as antigens (Herceptin-targeting HER-2/neu for breast cancer), antibodies, which sever the blood supply of the tumor, cytokines such as interferon α and β and immune inhibitors (PD-1 inhibitors) [114,115]. The gene discussed is ERBB2; the disease is breast carcinoma.